You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

124 Results
Guidelines and Advice
Status: Current
ID: GL 26-2
Version: 3
Mar 2021
Guidelines and Advice
Status: Current
ID: GL 27-2
Version: 2
Feb 2021
Guidelines and Advice
Status: Current
ID: GL END 5-7
Version: 3
Nov 2021
Guidelines and Advice
Status: Current
ID: GL 4-1
Version: 2
Jan 2021
Guidelines and Advice
Status: Archived
ID: 5-6c
Nov 2000
Guidelines and Advice
Status: Current
ID: GL-C50-10
Version: 1
May 2021
Guidelines and Advice
Status: Current
ID: GL-C50-27
Nov 2021
Guidelines and Advice
Status: Current
ID: GL-C50-32
Jan 2021
Drug
Quick Link(s):
Drug Monograph, Patient Info Sheet
Mar 2021
Drug
Other Name(s): Ibrance™
Quick Link(s):
Drug Monograph, Patient Info Sheet
May 2021
Regimen
Cancer Type:
Gastrointestinal, 
Hepatobiliary / Liver / Bile Duct
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
CISplatin,
gemcitabine
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2021
Regimen
Cancer Type:
Gynecologic, 
Ovary
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant, Palliative
Drugs Used:
PACLitaxel,
CISplatin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2021

Pages